NOVARTIS AG (NVSEF)
Clinical trial NCT05207709 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-03-01 → 2026-03-26 3. primary completion date: 2026-03-01 → 2026-03-26 4. enrollment: 456 → 61 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (16%) **Content type:** Clinical